A strategy for advancing for population-based scientific discovery using the metabolome: the establishment of the Metabolomics Society Metabolomic Epidemiology Task Group

Abstract
Metabolomic Epidemiology is a growing area of research within the metabolomics research community. In response to this, we describe the establishment of the Metabolomics Society Metabolomic Epidemiology Task Group. The overall mission of this group is to promote the growth and understanding of metabolomic epidemiology as an independent research discipline and to drive collaborative efforts that can shape the field. In this article we define metabolomic epidemiology and identify the key challenges that need to be addressed in order to advance population-based scientific discovery in metabolomics.
Funding Information
  • National Heart, Lung, and Blood Institute (R01HL123915, R01HL141826, R01HL141826, R01HL123915, K01HL146980)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK125273, R01 DK125273)
  • Swedish Heart Lung Blood (HLF 20180290, HLF 20200693)